Home

Parmax Pharma Ltd Quarterly Result

Image

Parmax Pharma Ltd

NSE: PARMAXPHARMA

Net Profit - Last Quarter

₹ -0.39 Cr.

Last updated on: Feb 23, 2025

Parmax Pharma Ltd Quarterly Results Key Highlights

  • The revenue of Parmax Pharma Ltd for the Dec '24 is ₹ 6.3 crore as compare to the Sep '24 revenue of ₹ 9.39 crore.
  • This represent the decline of -32.91%a1# The ebitda of Parmax Pharma Ltd for the Dec '24 is ₹ 0.12 crore as compare to the Sep '24 ebitda of ₹ 0.32 crore.
  • This represent the decline of -62.5%a1# The net profit of Parmax Pharma Ltd for the Dec '24 is ₹ -0.39 crore as compare to the Sep '24 net profit of ₹ -0.22 crore.
  • This represent the growth of 77.27%a1#.

Parmax Pharma Ltd Quarterly Results Analysis

Market Price of Parmax Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Parmax Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 202542.93
20 Feb 202543.83
19 Feb 202539.95
18 Feb 202541.8
17 Feb 202538.03
14 Feb 202541.07
13 Feb 202541
12 Feb 202540.5
11 Feb 202545
10 Feb 202547.99

Historical Revenue of Parmax Pharma Ltd

No data available

* All values are in crore

Historical EBITDA of Parmax Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Parmax Pharma Ltd

No data available

* All values are in crore

Parmax Pharma Ltd News Hub

Parmax Pharma reports standalone net profit of Rs 0.01 crore in the June 2024 quarter

Net profit of Parmax Pharma reported to Rs 0.01 crore in the quarter ended June 2024 as against net

Read more

16 Aug 24

Parmax Pharma to declare Quarterly Result

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 August 2024. Powere

Read more

09 Aug 24

Parmax Pharma to conduct AGM

Parmax Pharma announced that the Annual General Meeting (AGM) of the company will be held on 30 Sept

Read more

18 Sept 24

Parmax Pharma to discuss results

Parmax Pharma will hold a meeting of the Board of Directors of the Company on 14 November 2024 Power

Read more

07 Nov 24

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for Quarterly Results of Parmax Pharma Ltd

What key financial metrics are included in Parmax Pharma Ltd's quarterly results?

Key financial metrics in Parmax Pharma Ltd's quarterly results typically include revenue, net profit, earnings per share (EPS), and operating margins. Other metrics might include cash flow, operating expenses, and client metrics.

When does Parmax Pharma Ltd announce its quarterly results?

Parmax Pharma Ltd usually announces its quarterly results around mid-July for Q1, mid-October for Q2, mid-January for Q3, and mid-April for Q4, aligning with the end of each fiscal quarter. However, different finance companies have their respective schedules for announcing their quarterly results.

How does Parmax Pharma Ltd's quarterly performance impact its stock price?

Parmax Pharma Ltd's quarterly performance can lead to stock price volatility, with strong results often driving the price up, while disappointing results can cause it to drop. Investor sentiment and market expectations also play significant roles.

What is the impact of Parmax Pharma Ltd's quarterly results on dividends?

The impact of Parmax Pharma Ltd's quarterly results on dividends can influence dividend decisions, with strong performance potentially leading to increased or special dividends, while weaker results might result in stable or reduced dividends.

Are there any special announcements usually made during Parmax Pharma Ltd's quarterly results?

Yes, Parmax Pharma Ltd often makes special announcements during its quarterly results, including strategic updates, key client wins, and major contract renewals. They might also guide future performance and share insights on industry trends. These updates are typically highlighted in their press release. However, special announcements made during quarterly results may vary from company to company.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions